Metagenomi, Inc. Common Stock (MGX)
USD 3.11
(-8.26%)
USD 3.11
(-8.26%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -91.4 Million | 29.72 Million | 24.25 Million |
| Net Income | -68.25 Million | -43.59 Million | -21.44 Million |
| Depreciation & Amortization | 4.2 Million | 1.73 Million | 387 Thousand |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 6.92 Million | 1.96 Million | 375 Thousand |
| Change in working capital | -26.42 Million | 69.48 Million | 46.25 Million |
| Other non-cash items | 3.46 Million | 1.07 Million | 1.23 Million |
| Investing Cash Flow | 45.73 Million | -122.2 Million | -74.31 Million |
| Investments in PPE | -9.81 Million | -13.97 Million | -2.9 Million |
| Acquisitions | - | - | - |
| Investment purchases | -208.09 Million | -214.85 Million | -71.41 Million |
| Sales/Maturities of investments | 263.64 Million | 106.62 Million | - |
| Other Investing Activities | 55.54 Million | -108.22 Million | -71.41 Million |
| Financing Cash Flow | 1.01 Million | 239.59 Million | 39.92 Million |
| Debt repayment | - | - | -29.97 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 1.01 Million | 239.59 Million | 9.94 Million |
| Other Financing Activities | -3.28 Million | 239.59 Million | 9.94 Million |
| Accounts receivables | -2.45 Million | -1.27 Million | - |
| Accounts payables | -84 Thousand | 721 Thousand | 695 Thousand |
| Inventory | - | - | - |
| Other working capital | -30.29 Million | 65.66 Million | 44.22 Million |
| Cash at beginning of period | 190.51 Million | 43.39 Million | 53.53 Million |
| Cash at end of period | 145.85 Million | 190.51 Million | 43.39 Million |
| Capital Expenditure | -9.81 Million | -13.97 Million | -2.9 Million |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -44.66 Million | 147.11 Million | -10.13 Million |
| Free Cash Flow | -101.22 Million | 15.74 Million | 21.35 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.73 Million | -25.14 Million | -19.29 Million | -68.25 Million | -19.82 Million | -13 Million |
| Depreciation & Amortization | 1.3 Million | 1.27 Million | 1.2 Million | 4.2 Million | 1.15 Million | 1.01 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 4.51 Million | 5.05 Million | 2.46 Million | 6.92 Million | 3.26 Million | 656 Thousand |
| Change in working capital | -20.74 Million | -10.91 Million | -4.37 Million | -26.42 Million | -6.94 Million | -10.13 Million |
| Other non-cash items | 7.47 Million | 1.09 Million | 1.01 Million | 3.46 Million | 918 Thousand | 630 Thousand |
| Investing Cash Flow | -13.03 Million | -94.73 Million | 60.63 Million | 45.73 Million | 75.88 Million | -18.71 Million |
| Investments in PPE | -665 Thousand | -915 Thousand | -1.73 Million | -9.81 Million | -2.25 Million | -3.15 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -74.5 Million | -174.66 Million | -39.11 Million | -208.09 Million | - | -49.77 Million |
| Sales/Maturities of investments | 62.13 Million | 80.84 Million | 101.48 Million | 263.64 Million | 78.14 Million | 34.21 Million |
| Other Investing Activities | -12.37 Million | -93.81 Million | 62.36 Million | 55.54 Million | 78.14 Million | - |
| Financing Cash Flow | -2.03 Million | 86.53 Million | -1.33 Million | 1.01 Million | -1.91 Million | -39 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.03 Million | - | - | - | - | - |
| Common Stock Issuance | -2.03 Million | 86.53 Million | -1.33 Million | 1.01 Million | - | - |
| Other Financing Activities | - | 86.53 Million | -1.33 Million | -3.28 Million | -1.91 Million | - |
| Accounts receivables | 434 Thousand | 369 Thousand | 1.47 Million | -2.45 Million | -1.59 Million | -2.32 Million |
| Accounts payables | -1.42 Million | 3.15 Million | -2.52 Million | -84 Thousand | 1.55 Million | -323 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -19.75 Million | -10.36 Million | -5.25 Million | -30.29 Million | -8.87 Million | -8.37 Million |
| Cash at beginning of period | 102.55 Million | 145.85 Million | 107.14 Million | 190.51 Million | 56.89 Million | 101.74 Million |
| Cash at end of period | 61.18 Million | 107.8 Million | 145.85 Million | 145.85 Million | 107.14 Million | 56.89 Million |
| Capital Expenditure | -665 Thousand | -915 Thousand | -1.73 Million | -9.81 Million | -2.25 Million | -3.15 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -41.37 Million | -38.04 Million | 38.7 Million | -44.66 Million | 50.24 Million | -44.85 Million |
| Free Cash Flow | -26.97 Million | -30.76 Million | -22.32 Million | -101.22 Million | -25.98 Million | -29.24 Million |
9405
IVCGF
DALBHARAT
BOL
HTNGF
4588